DAVID
GARCIA AZORIN
PROFESOR ASOCIADO
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (6)
2024
-
Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
Frontiers in Neurology , Vol. 15
-
RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine
European Journal of Neurology, Vol. 31, Núm. 4
-
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937
-
Visual snow syndrome in patients with migraine: widening the clinical spectrum of the syndrome with permanent and episodic manifestations
Neurological Sciences, Vol. 45, Núm. 9, pp. 4437-4444
2022
-
Seizures and COVID-19: Results from the Spanish Society of Neurology’s COVID-19 registry
Journal of Clinical Neuroscience, Vol. 101, pp. 112-117
2021
-
Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry
Journal of the Neurological Sciences, Vol. 423